Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omics International is a global open-access publisher and scientific conference organizer that focuses on the life sciences, medicine, and technology sectors. The company manages a vast portfolio of online journals and hosts hundreds of annual events designed to facilitate the exchange of scientific information. However, the organization is widely recognized for its controversial business model, often categorized as "predatory publishing" due to allegations of deceptive marketing and lack of rigorous peer review. In 2019, the U.S. Federal Trade Commission successfully sued the company for misleading researchers, resulting in a multi-million dollar judgment. Despite these legal challenges, the company continues to operate as a major provider of scientific publishing services and academic forums.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omics International.